颈动脉粥样硬化的PET分子成像:系统综述
18F-FDG(49/53)和18F-NaF(5/53)是最常用示踪剂,分别显示颈壁炎症和微钙化;FDG摄取在有症状者高于无症状者,事件同侧高于对侧,并与年龄、男性、BMI及高血压、高胆固醇血症、糖尿病相关;NaF摄取与组织学微钙化强相关。
要点
- FDG-PET可显示颈动脉粥样硬化炎症成分,在一定程度上支持风险分层。
- 症状性颈动脉粥样硬化者FDG摄取高于无症状者,事件同侧高于对侧。
- NaF-PET显示微钙化,可区分粥样硬化与正常动脉,提示临床显著病变。
核心结论
- FDG-PET可显示颈动脉粥样硬化的炎症部分,在一定程度上实现风险分层。
- NaF-PET通过显示微钙化提示持续炎症的长期后果,可区分粥样硬化与正常动脉,并提示临床显著的颈动脉粥样硬化。
研究设计与样本
- 排除重复文献、社论、病例研究、PET可行性或可重复性研究以及终末期疾病或使用免疫抑制药物的患者。
- 使用Joanna Briggs Institute清单进行质量评估后,纳入53项研究共4472例患者,年龄47-91岁,男性占78.8%。
主要发现
- 18F-FDG(49/53)和18F-NaF(5/53)是最常用的示踪剂,分别用于显示颈动脉壁炎症和微钙化。
- 有症状颈动脉粥样硬化患者的颈动脉FDG摄取高于无症状患者,正常颈动脉FDG摄取最低。
- 在有症状的粥样硬化中,脑血管事件同侧颈动脉的FDG摄取高于对侧颈动脉。
- 健康个体中FDG摄取与年龄、男性性别和体重指数显著相关,患者中此外还与动脉高血压、高胆固醇血症和糖尿病相关。
- 组织学评估显示有症状患者微钙化与NaF摄取强相关;钙化的组织学证据与FDG摄取呈负相关,FDG摄取与巨噬细胞和CD68计数增加相关。
关键数值与推荐
- 共纳入53项研究,涵盖4472例患者,年龄47-91岁,男性占78.8%。
- 18F-FDG使用率为49/53,18F-NaF使用率为5/53。
临床怎么用
- FDG-PET可用于评估颈动脉粥样硬化炎症活动,辅助风险分层。
- NaF-PET可用于识别颈动脉微钙化,帮助区分粥样硬化与正常动脉。
- 结合FDG与NaF PET可能提供炎症与钙化互补信息,辅助临床显著颈动脉粥样硬化的判断。
局限性
- 排除了终末期疾病或使用免疫抑制药物的患者,可能限制结果外推。
- 纳入研究以FDG为主(49/53),NaF相关证据(5/53)相对有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To conduct a systematic review of articles on PET imaging of carotid atherosclerosis with emphasis on clinical usefulness and comparison with other imaging modalities. METHODS: Research articles reporting carotid artery PET imaging with different radiotracers until 30 November 2018 were systematically searched for in Medline/PubMed, Scopus, Embase, Google Scholar, and Cochrane Library. Duplicates were removed, and editorials, case studies, and investigations on feasibility or reproducibility of PET imaging and of patients with end-stage diseases or immunosuppressive medications were omitted. After quality assessment of included articles using Joanna Briggs Institute checklists, all eligible articles were reviewed. RESULTS: Of 1718 primary hits, 53 studies comprising 4472 patients, aged 47-91 years (78.8% males), were included and grouped under the following headlines: diagnostic performance, risk factors, laboratory findings, imaging modalities, and treatment. 18F-fluorodeoxyglucose (FDG) (49/53) and 18F-sodium fluoride (NaF) (5/53) were the most utilized tracers to visualize carotid wall inflammation and microcalcification, respectively. Higher carotid FDG uptake was demonstrated in patients with than without symptomatic carotid atherosclerosis. Normal carotid arteries presented with the lowest FDG uptake. In symptomatic atherosclerosis, carotid arteries ipsilateral to a cerebrovascular event had higher FDG uptake than the contralateral carotid artery. FDG uptake was significantly associated with age, male gender, and body mass index in healthy individuals, and in addition with arterial hypertension, hypercholesterolemia, and diabetes mellitus in patients. Histological assessment indicated a strong correlation between microcalcification and NaF uptake in symptomatic patients. Histological evidence of calcification correlated inversely with FDG uptake, which was associated with increased macrophage and CD68 count, both accounting for increased local inflammatory response. CONCLUSION: FDG-PET visualizes the inflammatory part of carotid atherosclerosis enabling risk stratification to a certain degree, whereas NaF-PET seems to indicate long-term consequences of ongoing inflammation by demonstrating microcalcification allowing discrimination of atherosclerotic from normal arteries and suggesting clinically significant carotid atherosclerosis.
引用
- Piri R, Gerke O, Høilund-Carlsen PF, et al. Molecular imaging of carotid artery atherosclerosis with PET: a systematic review. Eur J Nucl Med Mol Imaging. 2019. PMID: 31786626. doi:10.1007/s00259-019-04622-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。